Found: 44
Select item for more details and to access through your institution.
Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients--authors response.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 5, p. 1080, doi. 10.1093/jac/dkp064
- By:
- Publication type:
- Article
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 2, p. 380
- By:
- Publication type:
- Article
HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2008, v. 61, n. 6, p. 1362
- By:
- Publication type:
- Article
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).
- Published in:
- 2000
- By:
- Publication type:
- journal article
Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P41, doi. 10.1186/1758-2652-13-S4-P41
- By:
- Publication type:
- Article
Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study.
- Published in:
- Journal of the International AIDS Society, 2010, v. 13, p. P29, doi. 10.1186/1758-2652-13-S4-P29
- By:
- Publication type:
- Article
Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study.
- Published in:
- 2010
- By:
- Publication type:
- Abstract
Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity score.
- Published in:
- Infection, 2014, v. 42, n. 2, p. 295, doi. 10.1007/s15010-013-0542-8
- By:
- Publication type:
- Article
Nebulizer Performance: AFLM Study.
- Published in:
- Respiration, 1995, v. 62, n. S1, p. 13, doi. 10.1159/000196488
- By:
- Publication type:
- Article
Factors Associated With Virological Failure in HIV-1-Infected Patients Receiving Darunavir/Ritonavir Monotherapy.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
The Relationship between Levels of the Anti-HIV Drug Indinavir in Patients' Hair and Response to Treatment.
- Published in:
- Annals of Internal Medicine, 2002, v. 137, n. 8, p. I-48, doi. 10.7326/0003-4819-137-8-200210150-00004
- By:
- Publication type:
- Article
Evaluation of pharmacokinetic interaction between cetirizine and ritonavir, an HIV-1 protease inhibitor, in healthy male volunteers.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 4, p. 267, doi. 10.1007/s00228-005-0917-6
- By:
- Publication type:
- Article
Comparison of lithium concentrations in red blood cells and plasma in samples collected for TDM, acute toxicity, or acute-on-chronic toxicity.
- Published in:
- European Journal of Clinical Pharmacology, 2003, v. 59, n. 8/9, p. 583, doi. 10.1007/s00228-003-0670-7
- By:
- Publication type:
- Article
Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study.
- Published in:
- HIV Medicine, 2017, v. 18, n. 9, p. 704, doi. 10.1111/hiv.12506
- By:
- Publication type:
- Article
Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients.
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patients S Lambert-Niclot et al. Atazanavir inhibitory quotient in first-line therapy
- Published in:
- HIV Medicine, 2010, v. 11, n. 10, p. 666, doi. 10.1111/j.1468-1293.2010.00839.x
- By:
- Publication type:
- Article
Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study.
- Published in:
- HIV Medicine, 2008, v. 9, n. 9, p. 738, doi. 10.1111/j.1468-1293.2008.00616.x
- By:
- Publication type:
- Article
Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial.
- Published in:
- HIV Medicine, 2008, v. 9, n. 8, p. 625, doi. 10.1111/j.1468-1293.2008.00606.x
- By:
- Publication type:
- Article
GENOPHAR: a randomized study of plasma drug measurements in association with genotypic resistance testing and expert advice to optimize therapy in patients failing antiretroviral therapy.
- Published in:
- HIV Medicine, 2004, v. 5, n. 5, p. 352, doi. 10.1111/j.1468-1293.2004.00234.x
- By:
- Publication type:
- Article
Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV-infected patients.
- Published in:
- HIV Medicine, 2004, v. 5, n. 4, p. 307, doi. 10.1111/j.1468-1293.2004.00226.x
- By:
- Publication type:
- Article
Pharmacokinetics of emtricitabine, didanosine and efavirenz administered once-daily for the treatment of HIV-infected adults (pharmacokinetic substudy of the ANRS 091 trial)
- Published in:
- 2004
- By:
- Publication type:
- Journal Article
Low increase in serum lipids in patients receiving a combination of ritonavir, saquinavir and efavirenz.
- Published in:
- HIV Medicine, 2002, v. 3, n. 4, p. 287, doi. 10.1046/j.1468-1293.2002.00126.x
- By:
- Publication type:
- Article
Testing for levamisole and cocaine in hair samples for the diagnosis of levamisole-related panniculitis.
- Published in:
- 2015
- By:
- Publication type:
- Letter to the Editor
Stability of ritonavir soft capsule formulation in patients with and without a refrigerator at home in Côte d'Ivoire.
- Published in:
- 2006
- By:
- Publication type:
- Journal Article
Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Persistent low-level viraemia in antiretroviral treatment-experienced patients is not linked to viral resistance or inadequate drug concentrations.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Letermovir breakthroughs during the French Named Patient Programme: interest of monitoring blood concentration in clinical practice.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long-term follow-up of HIV-infected patients on dolutegravir monotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Resistance profile and treatment outcomes in HIV-infected children at virological failure in Benin, West Africa.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Non-virological response to a dolutegravir-containing regimen in a patient harbouring a E157Q-mutated virus in the integrase region.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 6, p. 1921, doi. 10.1093/jac/dkv012
- By:
- Publication type:
- Article
Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapy.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Expression pattern of the CXCL12/ CXCR4- CXCR7 trio in Kaposi sarcoma skin lesions.
- Published in:
- British Journal of Dermatology, 2016, v. 175, n. 6, p. 1251, doi. 10.1111/bjd.14748
- By:
- Publication type:
- Article
Extensive levamisole-induced vasculitis.
- Published in:
- Clinical & Experimental Dermatology, 2017, v. 42, n. 4, p. 413, doi. 10.1111/ced.13085
- By:
- Publication type:
- Article